OSYMFORZ Trademark

Trademark Overview

On Thursday, November 21, 2024, a trademark application was filed for OSYMFORZ with the United States Patent and Trademark Office. The USPTO has given the OSYMFORZ trademark a serial number of 98865075. The federal status of this trademark filing is APPROVED FOR PUBLICATION as of Saturday, April 5, 2025. This trademark is owned by Ultragenyx Pharmaceutical Inc.. The OSYMFORZ trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Pharmaceutical, scientific, and medical research and development in the field of bone, genetic, joint, metabolic, musculoskeletal, osteopathic, orthopedic, and skeletal diseases and disorders; scientific research in the nature of conducting clinical trials for others in the field of bone, genetic, joint, metabolic, musculoskeletal, osteopathic, orthopedic, and skeletal diseases and disorders; scientific and medical research, namely, compiling and sharing of patient data for research purposes in the field of bone, genetic, joint, metabolic, musculoskeletal, osteopathic, orthopedic, and skeletal diseases and disorders; providing medical research and scientific research information in the field of bone, genetic, joint, metabolic, musculoskeletal, osteopathic, orthopedic, and skeletal diseases and disorders; providing medical research and scientific research information in the field of bone, genetic, joint, metabolic, musculoskeletal, osteopathic, orthopedic, and skeletal diseases and diso...
osymforz

General Information

Serial Number98865075
Word MarkOSYMFORZ
Filing DateThursday, November 21, 2024
Status680 - APPROVED FOR PUBLICATION
Status DateSaturday, April 5, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesPharmaceutical, scientific, and medical research and development in the field of bone, genetic, joint, metabolic, musculoskeletal, osteopathic, orthopedic, and skeletal diseases and disorders; scientific research in the nature of conducting clinical trials for others in the field of bone, genetic, joint, metabolic, musculoskeletal, osteopathic, orthopedic, and skeletal diseases and disorders; scientific and medical research, namely, compiling and sharing of patient data for research purposes in the field of bone, genetic, joint, metabolic, musculoskeletal, osteopathic, orthopedic, and skeletal diseases and disorders; providing medical research and scientific research information in the field of bone, genetic, joint, metabolic, musculoskeletal, osteopathic, orthopedic, and skeletal diseases and disorders; providing medical research and scientific research information in the field of bone, genetic, joint, metabolic, musculoskeletal, osteopathic, orthopedic, and skeletal diseases and disorders

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, November 21, 2024
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameUltragenyx Pharmaceutical Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNovato, CA 94949

Trademark Events

Event DateEvent Description
Thursday, November 21, 2024NEW APPLICATION ENTERED
Monday, March 24, 2025ASSIGNED TO EXAMINER
Wednesday, March 26, 2025NON-FINAL ACTION E-MAILED
Thursday, November 21, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, March 26, 2025NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, March 31, 2025CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, March 31, 2025TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, March 26, 2025NON-FINAL ACTION WRITTEN
Monday, March 31, 2025TEAS/EMAIL CORRESPONDENCE ENTERED
Saturday, April 5, 2025APPROVED FOR PUB - PRINCIPAL REGISTER

Related Keywords

osymforz research musculoskeletal metabolic osteopathic joint orthopedic skeletal diseases scientific field